Table 2. Tumor characteristics, pathological stage and postoperative clinical evolution.
| Data | VATS (n=42) | OPEN (n=75) | P value |
|---|---|---|---|
| Preoperatory chemotherapy | |||
| No | 41 (97.62%) | 55 (73.33%) | 0.00 |
| T stage, n (%) | |||
| T1a | 16 (30.09%) | 18 (24.00%) | |
| T1b | 12 (28.57%) | 17 (22.67%) | 0.005 |
| T2a | 10 (23.81%) | 17 (22.67%) | |
| Radiological image, n (%) | 0.02 | ||
| Lung nodule | 30 (71.43%) | 27 (45.76%) | |
| Mass | 9 (21.43%) | 29 (49.15%) | |
| Lobar Atelectasia | 3 (7.14%) | 3 (5.08%) | |
| Surgery time (h, mean ± SD) | 3.86±0.9 | 4.11±1.31 | 0.30 |
| ICU admission (days, mean ± SD) | 1.05±0.31 | 1.72±2.21 | 0.02 |
| Hospital admission (days, mean ± SD) | 5.57±2.64 | 8.19±4.48 | 0.00 |
| Complications, n (%) | 13 (30.9%) | 40 (53.3%) | 0.015 |
ICU, intensive care unit; VATS, video-assisted thoracic surgery.